Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Current assets
Cash
Prepaid expenses
Total current assets
Cash and marketable securities held in Trust Account
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY(DEFICIT)
Current liabilities
Accounts payable and accrued expenses
Note payable—related party
Total current liabilities
Warrant liability
Deferred underwriting fee payable
Total liabilities
Ordinary Shares subject to possible redemption, 26,551,482 shares at September 30, 2022 and December 31, 2021, at redemption value
Shareholders' Equity (Deficit):
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none outstanding
Common stock, value
Common Class A
Common Class B
Additional paid in capital
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities and shareholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support